Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ('Innate' or the 'Company'), announced today that Yannis Morel, Chief Operating Officer, will present at the AACR Oncology...